Megakaryocytes contribute to the bone marrow-matrix environment by expressing fibronectin, type IV collagen, and laminin

Stem Cells

Volumn 32, Issue 4, 2014, Pages 926-937

  Malara, Alessandro ^a,b   Currao, Manuela ^a,b   Gruppi, Cristian ^a   Celesti, Giuseppe ^c   Viarengo, Gianluca ^b   Buracchi, Chiara ^c   Laghi, Luigi ^c   Kaplan, David L ^d   Balduini, Alessandra ^a,b,d  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d Tufts University   (United States)

Author keywords

Bone marrow; Extracellular matrix; Megakaryocyte; Myelosuppression

Indexed keywords

COLLAGEN TYPE 6; FIBRONECTIN; LAMININ; SCLEROPROTEIN; ANTIMETABOLITE; COLLAGEN TYPE 4; FLUOROURACIL;

ANIMAL TISSUE; ARTICLE; BONE MARROW; BONE MARROW SUPPRESSION; EXTRACELLULAR MATRIX; HOMEOSTASIS; IN VITRO STUDY; IN VIVO STUDY; MEGAKARYOCYTE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; UPREGULATION; ANIMAL; BIOSYNTHESIS; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY; STEM CELL NICHE;

ANIMALS; ANTIMETABOLITES; BONE MARROW; COLLAGEN TYPE IV; FIBRONECTINS; FLUOROURACIL; GENE EXPRESSION REGULATION; LAMININ; MEGAKARYOCYTES; MICE; STEM CELL NICHE;

EID: 84896339804     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.1626     Document Type: Article

References (44)

1. Ohta M, Sakai T, Saga Y, et al. Suppression of hematopoietic activity in tenascin-C-deficient mice. Blood 1998; 1: 4074-4083.
2. Jacenko O, Roberts DW, Campbell MR, et al. Linking hematopoiesis to endochondral skeletogenesis through analysis of mice transgenic for collagen X. Am J Pathol 2002; 160: 2019-2034.
3. Kacena MA, Nelson T, Clough ME, et al. Megakaryocyte-mediated inhibition of osteoclast development. Bone 2006; 39: 991-999.
4. Ciovacco WA, Cheng YH, Horowitz MC, et al. Immature and mature megakaryocytes enhance osteoblast proliferation and inhibit osteoclast formation. J Cell Biochem 2010; 109: 774-781.
5. Winter O, Moser K, Mohr E, et al. Megakaryocytes constitute a functional component of a plasma cell niche in the bone marrow. Blood 2010; 116: 1867-1875.
6. Italiano JE Jr,., Richardson JL, Patel-Hett S, et al. Angiogenesis is regulated by a novel mechanism: Pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood 2008; 111: 1227-1233.
7. Ciurea SO, Merchant D, Mahmud N, et al. Pivotal contributions of megakaryocytes to the biology of idiopathic myelofibrosis. Blood 2007; 110: 986-993.
8. Badalucco S, Di Buduo CA, Campanelli R, et al. Involvement of TGFβ1 in autocrine regulation of proplatelet formation in healthy subjects and patients with primary myelofibrosis. Haematologica 2013; 98: 514-517.
9. Malara A, Gruppi C, Rebuzzini P, et al. Megakaryocyte-matrix interaction within bone marrow: New roles for fibronectin and factor XIII-A. Blood 2011; 117: 2476-2483.
10. Eliades A, Papadantonakis N, Bhupatiraju A, et al. Control of megakaryocyte expansion and bone marrow fibrosis by lysyl oxidase. J Biol Chem 2011; 286: 27630-27638.
11. Haylock DN, Nilsson SK,. Stem cell regulation by the hematopoietic stem cell niche. Cell Cycle 2005; 4: 1353-1355.
12. Scadden DT,. The stem-cell niche as an entity of action. Nature 2006; 441: 1075-1079.
13. Kaplan RN, Psaila B, Lyden D,. Niche-to-Niche migration of bone marrow-derived cells. Trends Mol Med 2007; 13: 72-81.
14. Yin T, Li L,. The stem cell niches in bone. J Clin Invest 2006; 116: 1195-1201.
15. Avecilla ST, Hattori K, Heissig B, et al. Chemokine-mediated interaction of hematopoietic progenitors with the bone marrow vascular niche is required for thrombopoiesis. Nat Med 2004; 10: 64-71.
16. Italiano JE Jr,., Patel-Hett S, Hartwig JH., Mechanics of proplatelet elaboration. J Thromb Haemost 2007; 5 (suppl 1): 18-23.
17. Hooper AT, Butler JM, Nolan DJ, et al. Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell 2009; 4: 263-274.
18. Larson MK, Watson SP,. Regulation of proplatelet formation and platelet release by integrin alpha IIb beta3. Blood 2006; 108: 1509-1514.
19. Balduini A, Pallotta I, Malara A, et al. Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes. J Thromb Haemost 2008; 6: 1900-1907.
20. Fox NE, Kaushansky K,. Engagement of integrin alpha4beta1 enhances thrombopoietin-induced megakaryopoiesis. Exp Hematol 2005; 33: 94-99.
21. Jiang F, Jia Y, Cohen I,. Fibronectin- and protein kinase C-mediated activation of ERK/MAPK are essential for proplatelet-like formation. Blood 2002; 99: 3579-3584.
22. Matsunaga T, Fukai F, Kameda T, et al. Potentiated activation of VLA-4 and VLA-5 accelerates proplatelet-like formation. Ann Hematol 2012; 91: 1633-1643.
23. Chen Z, Naveiras O, Balduini A, et al. The May-Hegglin anomaly gene MYH9 is a negative regulator of platelet biogenesis modulated by the Rho-ROCK pathway. Blood 2012; 110: 171-179.
24. Pallotta I, Lovett M, Rice W, et al. Bone marrow osteoblastic niche: A new model to study physiological regulation of megakaryopoiesis. PLoS One 2009; 4: e8359.
25. Chang Y, Auradé F, Larbret F, et al. Proplatelet formation is regulated by the Rho/ROCK pathway. Blood 2007; 109: 4229-4236.
26. Lai Y, Sun Y, Skinner CM, et al. Reconstitution of marrow-derived extracellular matrix ex vivo: A robust culture system for expanding large-scale highly functional human mesenchymal stem cells. Stem Cells Dev 2010; 19: 1095-1107.
27. Celebi B, Mantovani D, Pineault N,. Effects of extracellular matrix proteins on the growth of hematopoietic progenitor cells. Biomed Mater 2011; 6: 055011.
28. Takaku T, Malide D, Chen J, et al. Hematopoiesis in 3 dimensions: Human and murine bone marrow architecture visualized by confocal microscopy. Blood 2010; 116: e41-55.
29. Nilsson SK, Debatis ME, Dooner MS, et al. Immunofluorescence characterization of key extracellular matrix proteins in murine bone marrow in situ. J Histochem Cytochem 1998; 46: 371-377.
30. Tavassoli M, Aoki M,. Localization of megakaryocytes in the bone marrow. Blood Cells 1989; 15: 3-14.
31. Tavassoli M, Aoki M,. Migration of entire megakaryocytes through the marrow-blood barrier. Br J Haematol 1981; 48: 25-29.
32. Junt T, Schulz H, Chen Z, et al. Dynamic visualization of thrombopoiesis within bone marrow. Science 2007; 317: 1767-1770.
33. Li XM, Hu Z, Jorgensen ML, et al. High levels of acetylated low-density lipoprotein uptake and low tyrosine kinase with immunoglobulin and epidermal growth factor homology domains-2 (Tie2) promoter activity distinguish sinusoids from other vessel types in murine bone marrow. Circulation 2009; 120: 1910-1918.
34. Sanes JR,. The basement membrane/basal lamina of skeletal muscle. J Biol Chem 2003; 278: 12601-12604.
35. Yurchenco PD, Amenta PS, Patton BL,. Basement membrane assembly, stability and activities observed through a developmental lens. Matrix Biol 2004; 22: 521-538.
36. Balduini A, d'Apolito M, Arcelli D, et al. Cord blood in vitro expanded CD41 cells: Identification of novel components of megakaryocytopoiesis. J Thromb Haemost 2006; 4: 848-860.
37. Deutsch V, Hubel E, Kay S, et al. Mimicking the haematopoietic niche microenvironment provides a novel strategy for expansion of haematopoietic and megakaryocyte-progenitor cells from cord blood. Br J Haematol 2010; 149: 137-149.
38. Gu YC, Kortesmaa J, Tryggvason K, et al. Laminin isoform-specific promotion of adhesion and migration of human bone marrow progenitor cells. Blood 2003; 101: 877-885.
39. Shimizu M, Minakuchi K, Moon M, et al. Difference in interaction of fibronectin with type I collagen and type IV collagen. Biochim Biophys Acta 1997; 1339: 53-61.
40. Rao CN, Margulies IM, Liotta LA,. Binding domain for laminin on type IV collagen. Biochem Biophys Res Commun 1985; 128: 45-52.
41. Dhanjal TS, Pendaries C, Ross EA, et al. A novel role for PECAM-1 in megakaryocytokinesis and recovery of platelet counts in thrombocytopenic mice. Blood 2007; 109: 4237-4244.
42. Radley JM, Scurfield G,. Effects of 5-fluorouracil on mouse bone marrow. Br J Haematol 1979; 43: 341-351.
43. Kopp HG, Avecilla ST, Hooper AT, et al. Tie2 activation contributes to hemangiogenic regeneration after myelosuppression. Blood 2005; 106: 505-513.
44. Papadantonakis N, Matsuura S, Ravid K,. Megakaryocyte pathology and bone marrow fibrosis: The lysyl oxidase connection. Blood 2012; 120: 1774-1781.